Sooyeon Oh

Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF

Triple-negative breast cancer molecular subtyping and treatment progress

Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer

A randomised phase II study of combination chemotherapy with epirubicin, cisplatin and capecitabine (ECX) or cisplatin and capecitabine (CX) in advanced gastric cancer

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Surgery and chemotherapy for intrahepatic cholangiocarcinoma

Randomized Prospective Phase II Study to Compare the Combination Chemotherapy Regimen Epirubicin, Cisplatin, and 5-Fluorouracil With Epirubicin, Cisplatin, and Capecitabine in Patients With Advanced or Metastatic Gastric Cancer

A phase II study of capecitabine plus cisplatin in metastatic triple-negative breast cancer patients pretreated with anthracyclines and taxanes

Meta-analysis of the REAL-2 and ML17032 trials: evaluating capecitabine-based combination chemotherapy and infused 5-fluorouracil-based combination chemotherapy for the treatment of advanced oesophago-gastric cancer

Pyroptosis: mechanisms and diseases

Measuring the multifaceted roles of mucin-domain glycoproteins in cancer

A Phase II Study of Epirubicin, Cisplatin and Capecitabine Combination Chemotherapy in Patients with Metastatic or Advanced Gastric Cancer

Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions

A randomized multicenter phase II study comparing capecitabine with irinotecan or cisplatin in metastatic adenocarcinoma of the stomach or esophagogastric junction

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma

Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

Gastric cancer

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer

Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer

Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035

Multicenter phase II study of capecitabine plus oxaliplatin as a first-line therapy in Chinese patients with advanced gastric cancer

Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness

Targeting hypersialylation in multiple myeloma represents a novel approach to enhance NK cell–mediated tumor responses

Chemotherapy for advanced gastric cancer

Disparities in Gastric Cancer Chemotherapy Between the East and West

Effects of Helicobacter pylori eradication for metachronous gastric cancer prevention: a randomized controlled trial

Risk Factors of Atrophic Gastritis and Intestinal Metaplasia in First-Degree Relatives of Gastric Cancer Patients Compared with Age-Sex Matched Controls

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer

Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors

A phase I / II trial of docetaxel, capecitabine, and cisplatin as a first line chemotherapy for advanced gastric cancer

The Diagnostic Validity of Citric Acid‐Free, High Dose ¹³C‐Urea Breath Test After Helicobacter pylori Eradication in Korea